KLA's September Beat and Strong December Guide Confirm AI Demand, but Valuation Still Demands Patience

What happened

KLA Corporation reportedly beat consensus estimates for its September quarter and provided December-quarter guidance above expectations, driven by AI-related demand for leading-edge fabs where its process-control tools are essential. This news corroborates the core narrative from the latest DeepValue master report, which already flagged KLA as a key beneficiary of rising process-control intensity and advanced packaging, but rated the stock WAIT at $271 due to high valuation (P/E ~76, EV/EBITDA ~66.9). The company's own filings and the master report highlight persistent risks: China still accounted for 33% of FY2025 revenue (30.2% in the most recent quarter) and export-license denials have previously reduced backlog and required returning customer deposits, while elevated DRAM costs create a ~100 bps gross-margin headwind through at least CY2026. The strong guide does not eliminate these risks nor justify the current multiple, and the master report's trim threshold of $310 is now closer, suggesting investors should avoid chasing the rally. For now, the report's base case of ~$275 implied value remains essentially unchanged, and the recommended approach stays: wait for a pullback toward the $220 attractive entry or clearer evidence of non-China replacement demand and packaging revenue realization.

Implication

The September beat and strong December guide affirm the AI-driven demand trajectory, but the master report's WAIT rating holds because the stock's valuation already embeds sustained upcycle and advanced packaging scaling to ~$1.0B in CY2026. Near-term upside is limited by the $310 trim threshold, and the current price around $271 leaves little margin of safety if WFE growth decelerates or export controls bite further. Persistent China exposure (30-33% of revenue) and the ~100 bps DRAM-cost drag on gross margin mean that even solid execution may not expand the multiple from current levels. The next two quarters remain critical: watch whether KLA reiterates the CY2026 packaging revenue target and whether China revenue share declines without hurting total growth, along with any disclosures about export-license denials or deposit returns. A disciplined approach would be to hold existing positions but avoid adding above $271, while preparing to buy meaningfully if the stock pulls back toward $220 or if the company demonstrates clear non-China replacement demand and stable gross margins above 60%.

Thesis delta

The thesis is unchanged in substance: KLA's fundamentals continue to validate the AI-driven process-control demand story, but the stock remains overvalued relative to the master report's intrinsic assessment. The strong September beat and December guide slightly increase the probability that the base case is achieved, but they also push the stock closer to the trim threshold, reinforcing the WAIT rating. No shift in the recommended action: await a better entry point or confirmation of non-China demand and packaging revenue.